Ana Glembotsky: A new RUNX1 hotspot mutation in FPD/AML
Ana Glembotsky shared on X:
“Happy to share our paper describing a new RUNX1 hotspot mutation in FPD/AML. It emphasizes the need for continuous diagnostic guidelines updating and data sharing among laboratories to improve the classification and interpretation of genetic variants.”
Paula Heller shared this post on X, adding:
“Great job! Very grateful for the longstanding fruitful collaboration with the University of Pavia.”
Authors: Laureano J Kamiya, Serena Barozzi, Federica Isidori, Daiana Ganiewich, Geraldine De Luca, Valeria Bozzi, Rosana F Marta, Federica Melazzini, Tommaso Pippucci, Paula G Heller, Ana C Glembotsky, Alessandro Pecci
Ana Glembotsky is an Adjunct Researcher at CONICET. She previously served as a board member of the Argentine Hemostasis and Thrombosis Group (Grupo CAHT). In 2016, she received the American Society of Hematology’s Visitor Training Program Award at Institut Gustave Roussy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023